Literature DB >> 2299717

Diagnosis of interstitial cystitis.

P Hanno1, R M Levin, F C Monson, C Teuscher, Z Z Zhou, M Ruggieri, K Whitmore, A J Wein.   

Abstract

We reviewed clinical and histological findings in 55 patients with interstitial cystitis and 21 with voiding dysfunction secondary to other pathological conditions. Of our interstitial cystitis patients 36% would fail to meet the research definition proposed at a recent National Institutes of Health workshop. Detrusor mastocytosis was present in 64% of our interstitial cystitis patients compared to 80% of the noninterstitial cystitis group. There was no statistically significant difference in mean detrusor mast cell counts between interstitial cystitis and noninterstitial cystitis patients. Biopsies of 12 patients who did meet the proposed National Institutes of Health research definition were evaluated by immunohistochemical techniques. Early results are inconclusive. These studies indicate that interstitial cystitis is a complex disease whose diagnosis presently still must be made from a symptom complex rather than from objective histological criteria, including mastocytosis or the presence of any specific immunoreactive cell.

Entities:  

Mesh:

Year:  1990        PMID: 2299717     DOI: 10.1016/s0022-5347(17)39933-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  The mysterious "urethral syndrome".

Authors:  W Brumfitt; J M Hamilton-Miller; W A Gillespie
Journal:  BMJ       Date:  1991-07-06

Review 2.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

3.  Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome.

Authors:  Ming-Huei Lee; Kun-Min Chang; Wen-Chen Tsai
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

4.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

Review 5.  Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.

Authors:  June D Cody; Ghulam Nabi; Norman Dublin; Samuel McClinton; David E Neal; Robert Pickard; Sze M Yong
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

6.  Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome.

Authors:  Jeffrey S Schachar; Robert J Evans; Graham E Parks; Joao Zambon; Gopal Badlani; Stephen J Walker
Journal:  Int Urogynecol J       Date:  2019-06-28       Impact factor: 2.894

Review 7.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  A model for the function of glycosaminoglycans in the urinary tract.

Authors:  C L Parsons
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2.

Authors:  Jayoung Kim; Susan K Keay; Sungyong You; Massimo Loda; Michael R Freeman
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

10.  'Omics' approaches to understanding interstitial cystitis/painful bladder syndrome/bladder pain syndrome.

Authors:  Sungyong You; Wei Yang; Jennifer T Anger; Michael R Freeman; Jayoung Kim
Journal:  Int Neurourol J       Date:  2012-12-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.